BLBAUPOST GROUP LLC/MA
Institutional investor · Portfolio as of Q1 2019
Top Holdings35 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
EBAY INC | 29.3M | $1.1B | 9.1% | $27.41 | +21.06% | 2 qtrssince 2018-Q4 | Increased 83 |
VIASAT INC | 13.7M | $1.1B | 8.9% | $58.03 | +33.55% | 2 qtrssince 2018-Q4 | Unchanged 0 |
FOX CORP - CLASS A | 27.3M | $1B | 8.4% | $33.43 | 0.00% | 1 qtr | New 99 |
LIBERTY GLOBAL PLC | 39.1M | $946.4M | 8.0% | — | — | 2 qtrssince 2018-Q4 | Increased 80 |
CHENIERE ENERGY INC | 12.6M | $862.6M | 7.2% | $55.26 | +18.22% | 2 qtrssince 2018-Q4 | Decreased 0 |
QORVO INC | 10.6M | $759.6M | 6.4% | $60.79 | +18.00% | 2 qtrssince 2018-Q4 | Decreased 0 |
ALLERGAN PLC | 4.8M | $698.3M | 5.9% | — | — | 2 qtrssince 2018-Q4 | Increased 62 |
SYNCHRONY FINANCIAL | 14.3M | $454.9M | 3.8% | $19.63 | +36.68% | 2 qtrssince 2018-Q4 | Decreased 0 |
P G & E CORP | 24.5M | $436.1M | 3.7% | $21.40 | -17.77% | 2 qtrssince 2018-Q4 | Increased 83 |
CBS CORP NEW | 8.5M | $406M | 3.4% | — | — | 2 qtrssince 2018-Q4 | Increased 93 |
CELGENE CORP | 4M | $377.4M | 3.2% | — | — | 1 qtr | New 87 |
MCKESSON CORP | 2.8M | $329.5M | 2.8% | $107.16 | +3.99% | 2 qtrssince 2018-Q4 | Increased 78 |
| 300M | $328.3M | 2.8% | — | — | — | Unchanged 0 | |
PIONEER NATURAL RESOURCE | 2M | $304.8M | 2.6% | — | — | 2 qtrssince 2018-Q4 | Decreased 0 |
COLONY CAP INC NEW | 49.7M | $264.3M | 2.2% | — | — | 2 qtrssince 2018-Q4 | Unchanged 0 |
Atara Biotherapeutics, Inc. | 6.4M | $253.6M | 2.1% | — | — | — | — |
ANTERO RESOURCES CORP | 28.6M | $252.4M | 2.1% | $9.21 | -4.13% | 2 qtrssince 2018-Q4 | Unchanged 0 |
TAKEDA PHARMACEUTIC-SP ADR | 10.7M | $217.3M | 1.8% | $19.07 | 0.00% | 1 qtr | New 71 |
THERAVANCE BIOPHARMA INC | 9.3M | $211M | 1.8% | $23.43 | -3.24% | 2 qtrssince 2018-Q4 | Unchanged 0 |
UNIVAR INC | 9.5M | $210.5M | 1.8% | — | — | 2 qtrssince 2018-Q4 | Unchanged 0 |
BAUPOST GROUP LLC/MA manages $11.9B across 35 positions as of Q1 2019. Top holdings: EBAY (9.1%), VSAT (8.9%), FOXA (8.4%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 4.5/5.0.
Active quarter - 8 new positions, 10 exits, 10 increased. Top move: FOXA (NEW, conviction 99). Portfolio: $11.9B across 35 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer